Notably, co-expression of TWIST1 and ZEB2 was significantly prevalent in OSCC patients with poorer overall survival particularly in patients with no lymph node metastasis. The gene discussed is ZEB2; the disease is metastatic malignant neoplasm in the lymph nodes.